10 employees
Novorex specializes in the development of molecule drugs targeting oncology and neurology diseases.
2020
NOVOREX IBERICA raised undisclosed on January 1, 2023
Investors: Company K Partners
NOVOREX IBERICA raised undisclosed on March 1, 2020
Investors: TIPS Town